Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 1999
Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograftF Kraeber-Bodéré, A Faibre-Chauvet, C Saï-Maurel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injectionsF Kraeber-Bodéré, A Faivre-Chauvet, C Saï-Maurel, et al.
Bioconjugate Chemistry|January 20, 2005
Synthesis of new bivalent peptides for applications in the Affinity Enhancement SystemL Morandeau, E Benoist, A Loussouarn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trialJ P Vuillez, F Kraeber-Bodéré, D Moro, et al.
International Journal of Pharmaceutics|June 27, 2007
Doubly radiolabeled liposomes for pretargeted radioimmunotherapyM Mougin-Degraef, C Bourdeau, E Jestin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgeryC de Labriolle-Vaylet, P Cattan, E Sarfati, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibodyJ Barbet, P Peltier, S Bardet, et al.
The Journal of Clinical Endocrinology and Metabolism|December 2, 2004
High frequency of bone/bone marrow involvement in advanced medullary thyroid cancerE Mirallié, J P Vuillez, S Bardet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1996
Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancerM Bardiès, S Bardet, A Faivre-Chauvet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trialF Kraeber-Bodéré, S Bardet, C A Hoefnagel, et al.
Pageof 11